Bellevue Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-39,550
| Closed | -$623K | – | 178 |
|
|
2022
Q2 | $623K | Sell |
39,550
-1,350
| -3% | -$21.3K | 0.01% | 146 |
|
|
2022
Q1 | $1.1M | Sell |
40,900
-700
| -2% | -$18.9K | 0.01% | 148 |
|
|
2021
Q4 | $1.54M | Buy |
41,600
+7,100
| +21% | +$263K | 0.02% | 150 |
|
|
2021
Q3 | $1.65M | Buy |
+34,500
| New | +$1.65M | 0.02% | 153 |
|